<i>In vivo</i> modifications of AcSDKP metabolism and haematopoiesis in mice treated with 5‐fluorouracil and Goralatide

Abstract

By improving our knowledge of the biology of AcSDKP in vivo during chemotherapy, our results could help to better define the therapeutic use of Goralatide.